Bausch Health Companies (BHC) Accounts Payables (2009 - 2026)
Bausch Health Companies (BHC) posted Accounts Payables of $593.0 million for Q2 2026, little changed sequentially from $593.0 million in Q1 2026, and down 5.42% YoY from $627.0 million in Q2 2025.
Bausch Health Companies (BHC) Accounts Payables (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Accounts Payables for 18 years, with the latest figure at $593.0 million in Q2 2026.
- Quarterly Accounts Payables fell 5.42% year-over-year to $593.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $593.0 million (down 5.42% YoY) and the FY2025 annual result came in at $600.0 million, up 1.87% from the prior year.
- Accounts Payables held at $593.0 million in Q2 2026 per BHC's latest filing, from $593.0 million in the prior quarter.
- Over five years, Accounts Payables peaked at $719.0 million in Q4 2023 and troughed at $471.0 million in Q1 2022.
- A 5-year average of $583.6 million and a median of $591.0 million in 2024 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2023 and 2024: Accounts Payables surged 38.0% in 2023, then declined 18.08% in 2024.
- Over 5 years, Accounts Payables stood at $521.0 million in 2022, then jumped by 38.0% to $719.0 million in 2023, then dropped by 18.08% to $589.0 million in 2024, then grew by 1.87% to $600.0 million in 2025, then retreated by 1.17% to $593.0 million in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $593.0 million, $593.0 million, and $600.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 356.00 Mn |
| 10 | Bausch Health Companies | 2.42 Bn | 586.38 Mn | 2.10 Bn | 593.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 593.00 Mn |
| Mar 31, 2026 | 593.00 Mn |
| Dec 31, 2025 | 600.00 Mn |
| Sep 30, 2025 | 616.00 Mn |
| Jun 30, 2025 | 627.00 Mn |
| Mar 31, 2025 | 620.00 Mn |
| Dec 31, 2024 | 589.00 Mn |
| Sep 30, 2024 | 667.00 Mn |
| Jun 30, 2024 | 579.00 Mn |
| Mar 31, 2024 | 642.00 Mn |
| Dec 31, 2023 | 719.00 Mn |
| Sep 30, 2023 | 569.00 Mn |
| Jun 30, 2023 | 515.00 Mn |
| Mar 31, 2023 | 561.00 Mn |
| Dec 31, 2022 | 521.00 Mn |
| Sep 30, 2022 | 486.00 Mn |
| Jun 30, 2022 | 536.00 Mn |
| Mar 31, 2022 | 471.00 Mn |
| Dec 31, 2021 | 407.00 Mn |
| Sep 30, 2021 | 455.00 Mn |